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Background: Researchers have shown that patients with type 2 diabetes have a lower quality 
of life than the general population and also somewhat lower than patients with other chronic 
diseases. Thus one of the most important outcomes of treatment is optimizing the quality of 
life of the patient. This study examines the factors that most strongly inﬂ  uence the quality of 
life of patients with type 2 diabetes.
Methods: 200 patients with type 2 diabetes were studied in Estonia in 2004–2005. A patient 
blood sample, taken during a visit to the family doctor, was collected. The family doctor also 
provided data on each patient’s body mass index (BMI), blood pressure, and medications for 
treatment of type 2 diabetes. Patients completed a SF-36 during a doctor visit, and also a special 
questionnaire which we provided to study their awareness about diabetes type 2.
Results: The mean age of the respondents was 64.7 (±11.1) years and the mean duration of 
the diabetes was 7.5 (±1.8) years. Logistic regression analysis showed that quality of life was 
most signiﬁ  cantly affected by awareness of the complications and risk-factors of diabetes, and 
by the age, duration of the disease, and BMI of the patient. Patients who were less aware had a 
signiﬁ  cantly higher quality of life score (p   0.001 in all cases). The age and BMI of the patients 
as well as the duration of the diabetes all lowered the score of the quality of life.
Conclusions: The results suggest that the main challenges for physicians in management of 
diabetes type 2 are modifying patient BMI and patient awareness.
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Introduction
In 2000, the World Health Organization estimated that more than 177 million people 
have diabetes. By 2025, this ﬁ  gure will top 300 million. Patients with type 2 diabetes 
have a high risk of complications such as retinopathy, nephropathy, lower extremity 
amputations, coronary artery disease, and cardiovascular disease (Turner et al 1988). 
Researchers have shown that as a result of these complications, the quality of life of 
patients with type 2 diabetes is remarkably lower than the quality of life of the general 
population (Rubin and Peyrot 1999) and also somewhat lower than patients with other 
chronic diseases (U.K. Prospective Diabetes Study Group 1999). Most complications 
are preventable and a key strategy is metabolic control through a combination of diet, 
exercise, and medication. The level of hemoglobin A1c (HbA1c) has been found 
to be related to good diabetic control (Barr et al 2002). However, the relationship 
between glycemic control and the quality of life of patients with type 2 diabetes is 
unclear. Some studies have shown that improved HbA1c is associated with short-term 
improvement in quality of life (Testa and Simonson 1998), while others showed no 
association (Bagne et al 1995; Aalto et al 1997). Directly quantiﬁ  able endpoints, such 
as microvascular disease, macrovascular disease, and laboratory values, are typically 
assessed as outcomes of good quality of care. Still, these reﬂ  ect disease control rather 
than the patient quality of life (Lau et al 2004). Researchers have found that physician Patient Preferences and Adherence 2008:2 22
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ratings of patient health do not necessarily correspond to 
patient ratings (Nerenz et al 1992). Patients may feel that 
severe dietary restriction and daily self-administration of 
oral medication or insulin also negatively affect their quality 
of life (Redekop et al 2002). Optimizing patient quality of 
life is a signiﬁ  cant treatment outcome. Therefore examining 
how patients with type 2 diabetes understand the factors that 
determine their quality of life is important.
The aim of the study was to examine which factors most 
strongly inﬂ  uence the quality of life of patients with type 2 
diabetes.
Methods
The study was conducted in 2004–2005 in Estonia. A random 
sample of 40 doctors was constituted from the list of 163 
family doctors of the Estonian Society of Family Doctors 
who had participated in our previous study (Rätsep 2006). 
Twenty-seven of the selected doctors agreed to participate in 
this study and 21 provided patient data. Every doctor sent a 
coded list of their patients with type 2 diabetes. From this list, 
10 randomly selected patients were allocated to this study. 
All patients with type 2 diabetes were considered eligible, 
irrespective of age, duration of diabetes, and treatment. The 
family doctors were asked to recruit those patients who had 
been selected for the study. If one patient did not agree, 
the next patient on the list was selected. During a visit to 
the family doctor, the patients signed an informed consent 
document, to conﬁ  rm their participation in the study. The 
family doctors then took a blood sample from each patient 
to measure HbA1c, measured each patient’s height, weight, 
and blood pressure, and listed each patient’s medications for 
treating type 2 diabetes.
During the family doctor visit, patients completed 
the Rand 36-item short form health survey (SF-36), and 
gave the completed form to the doctor, who returned it to 
the investigators. The SF-36 data were scored according 
to the methods suggested in the SF-36 Health Survey: 
Manual and Interpretation Guide (Ware et al 1993). The 
eight domains used to assess patient health status in this 
analysis were: Physical Functioning, Role-Physical, 
Bodily Pain, General Health, Vitality, Role-Emotional, 
Social Functioning, and Mental Health. Raw scale scores 
were transformed to 0–100 scales, in which higher scores 
consistently represent better health status in all the dimen-
sions measured.
A special questionnaire for the patients was developed 
by the research team, which included questions about their 
personal characteristics, duration of type 2 diabetes, and 
other potential determinants of quality of life, for example, 
smoking status, knowledge about the disease and its risk 
factors and complications, as well as information sources 
concerning diabetes. The questionnaire was piloted before 
being used in the main study, and improved according to 
the results gained. Patients were asked about their knowledge 
of risk factors and complications of diabetes. The questions 
were very simple and had multiple choices, for example, “Do 
you know which kind of complications diabetes type 2 has?” 
If the patient had at least 75% of the answers right, he/she 
was coded as being “aware” of the nature of the disease.
The study was approved by the Ethics Review Committee 
on Human Research of the Tartu University.
Statistics
The Statistical Package for the Social Sciences (SPSS 10.0) 
for Windows was used in the analysis. Associations between 
patient characteristics and the self-reported quality of life of 
the patients were analyzed using nonparametric tests (Mann-
Whitney U test or Kruskal-Wallis test). Nonparametric tests 
were used because the subscales of SF-36 were not normally 
distributed. Factors inﬂ  uencing the health of patients with type 
2 diabetes were analyzed using logistic regression analysis. 
Factors used in the logistic regression model were 1) patient 
related factors: age, gender, body mass index (BMI), smoking 
status, awareness of disease, and 2) disease related factors: 
duration of diabetes, treatment regimen (diet, oral medica-
tion, or insulin), HbA1c level, and blood pressure level. Any 
p-values lower than 0.05 were considered signiﬁ  cant.
Results
Altogether 200 patients with type 2 diabetes were studied; 
69% of them were females and 31% were males (Table 1). 
The mean age of the respondents was 64.7 years (±11.1) and 
the mean duration of the diabetes was 7.5 (±1.8) years. Most 
of the patients (70%) were receiving only oral treatment; 
16% were receiving insulin treatment for diabetes (Table 1). 
Only one-fourth (24%) of the patients were classiﬁ  ed as 
“being aware” of the complications and the risk factors of 
their disease.
Analysis showed the existence of several important links 
between patient characteristics and their perceived health sta-
tus. The older the patient, the lower the self-reported quality of 
life (Table 2). Only the emotional well being of patients with 
type 2 diabetes was not inﬂ  uenced by age. Whether or not the 
patient was aware of the complications and risk factors of their 
disease also signiﬁ  cantly inﬂ  uenced all sub-scales of quality 
of life. Patients with higher awareness presented a lower score Patient Preferences and Adherence 2008:2 23
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of quality of life (p   0.001 in all cases) (Table 2). The sex 
of the patient, duration of diabetes, smoking status, and body 
mass index also had an important inﬂ  uence on most of the 
sub-scales of quality of life. The type of treatment received 
for type 2 diabetes had only a minor effect, and the level of 
glycosylated hemoglobin had no effect, on the quality of life 
of patients with type 2 diabetes (Table 2).
When accounting for all the variables listed in Table 1, 
logistic regression analysis showed that quality of life was 
most signiﬁ  cantly affected by the extent of the patient’s 
awareness of the complications and risk factors of diabetes, 
and by age, duration of disease, and BMI (Table 3). Patients 
who were not well informed had a signiﬁ  cantly higher quality 
of life score. Patients’ age, BMI, and duration of diabetes all 
lowered the quality of life score (Table 3).
Discussion
This Estonian study aimed to establish the most signiﬁ  cant 
factors that inﬂ  uence the quality of life of patients with 
type 2 diabetes. So far this is the ﬁ  rst study on the quality of 
health of diabetes patients in Estonia.
Patient-perceived health status was measured using 
the SF-36 health survey instrument, which is approved as 
appropriate for examining relationships between patient 
experience with diabetes, quality of life and other chronic 
diseases, and is reliable and valid in assessing of diabetic 
health status (Jacobson et al 1994; Woodcock 2001). The 
average values of SF-36 in different domains demonstrated, 
as expected, lower values when compared with population 
averages (Lai et al 2001).
Several studies are being and have been conducted to 
ﬁ  nd out which factors inﬂ  uence the quality of life of patients 
with type 2 diabetes. The results have been contradictory, 
however, especially concerning the effect of the metabolic 
control of diabetes on quality of life (Weinberger et al 1994; 
Larsson et al 1999), the treatment regimen (Ware et al 1993; 
U.K. Prospective Diabetes Study Group 1999; Redekop et al 
2002; Saito et al 2006), and the duration of the disease (Aalto 
et al 1997; Redekop et al 2002; Saito et al 2006). Although by 
using univariate analysis we found that the sex of the patient, 
smoking status, and treatment type had some effect on the 
health-related quality of life, these factors were not signiﬁ  cant 
after adjustment for other variables. Only the age and body 
mass index of the patient, as well as the duration of diabetes 
and whether the patient was aware of the complications and 
risk factors of the disease, had an independent effect on the 
quality of health and life. Older patients with type 2 diabetes 
assessed their quality of life as being signiﬁ  cantly lower than 
younger patients, especially concerning physical function-
ing, role limitations due to physical functioning, emotional 
functioning, and social functioning. These findings are 
consistent with other studies conducted on diabetes patients 
(Caruso et al 2000; Redekop et al 2002) and also with studies 
on the general population (McHorney et al 1994). The effect 
of obesity in lowering the health-related quality of life of 
patients with type 2 diabetes, and the general population, was 
found to be similar in all studies (Redekop et al 2002; Jia and 
Lubetkin 2005; Huang et al 2006). In our study obese patients 
had especially low ratings in the emotional and physical role 
scales. It seems that the main challenge for doctors, and 
patients with type 2 diabetes, is promoting regular exercise 
and weight loss, which are shown to improve the functional 
as well as emotional status of patients (Glasgow et al 1997; 
Caruso et al 2000; Maddigan et al 2005). Moreover, research-
ers have found that the level of self-reported exercise was the 
only signiﬁ  cant self-management behavior to predict quality 
of life and body mass index (Glasgow et al 1997; Maddigan 
Table 1 Characteristics of respondents and distribution of 
SF-36 scales
Patient characteristics (N = 200) 
Mean (SD) age (years)  64.7 (±11.1)
Mean duration of type 2 diabetes (years)  7.5 (±1.8)
Mean BMI index  33.0 (±6.0)
Mean HbA1c level  7.5 (±6.7)
Treatment type 
 Nonpharmacological  14%
 Only  oral  70%
 Insulin  16%
Smoking status 
 Yes  16%
 No  84%
Mean blood pressure level (mmHg) 
 Systolic  149.3 (±18.3)
 Diastolic  86.2 (±11.9)
Gender 
 Female  61%
 Male  39%
Awareness of the disease and its complications 
 Yes  24%
 No  76%
Mean (SD) SF-36 scores 
 Physical  functioning  54.0  (±30.1)
 Role  functioning/physical  38.1  (±42.2)
  Role functioning/emotional  41.6 (±44.8)
 Energy/fatigue  43.7  (±18.4)
  Emotional well being  61.5 (±20.0)
 Social  functioning  61.3 (±28.2)
 Pain  53.4  (±30.9)
 General  health  35.3 (±18.1)
Abbreviations: BMI, body mass index; HbA1c, hemoglobin A1c; SF-36, Rand 
36-item short form health survey.Patient Preferences and Adherence 2008:2 24
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et al 2005). However, the level of exercise should be optimal, 
because beyond that, the effect of exercise on quality of life 
becomes more negative (Watkins et al 2000).
Previous studies have shown controversial results on the 
effect of the duration of diabetes on quality of life. Most stud-
ies have found no effect (Aalto et al 1997; Rubin and Peyrot 
1999; Redekop et al 2002), but some have shown a negative 
effect (Wubben and Porterﬁ  eld 2005; Saito et al 2006). Our 
study conﬁ  rms the negative effect of duration of diabetes on 
the energy and general health of the patient, as well as on 
emotional well-being and social functioning. There could be 
different reasons for this ﬁ  nding. Development of complica-
tions in the later stage of the disease, decreases quality of life. 
In the years of its duration, diabetes clearly has a tendency to 
worsen. As complications develop, new symptoms emerge 
and the treatment regimen tends to become more complex.
The key question is how patients manage their disease. 
A positive connection has been found between active, 
Table 2 Patient and disease-related characteristics and SF-36 sub-scales (mean scores of the sub-scales and SD)
Patient charac-
teristics/SF-36 
sub-scales
Physical 
function
Role 
functioning/ 
Physical
Role 
functioning/ 
Emotional
Energy/ 
Fatigue
Emotional 
well being
Social 
functioning
Pain General 
health
Age
   55 77.8 (21.8)** 71.8 (38.0)** 73.3 (37.5)** 50.3 (16.6)** 63.5 (24.8) 76.9 (24.8)** 65.6 (30.5)* 42.6 (17.6)**
  55–69 57.4 (28.1) 37.8 (41.3) 40.5 (44.7) 45.1 (18.8) 61.2 (27.1) 61.3 (27.1) 53.2 (30.5) 35.5 (17.9)
   70 35.9 (26.3) 20.8 (34.6) 26.8 (40.6) 37.9 (17.6) 60.9 (28.3) 52.8 (28.3) 46.9 (830.5) 31.0 (17.7)
Sex
  Male 60.8 (28.9)** 42.5 (42.6) 47.6 (44.7) 45.8 (18.6) 62.0 (20.3) 65.8 (29.4)* 56.2 (31.8) 37.4 (19.2)
  Female 49.6(30.2) 35.3 (35.3) 37.6 (44.7) 42.3 (18.3) 61.2 (19.9) 58.4 (27.2) 51.6 (30.5) 33.9 (17.2)
Duration ofdiabetes 
(years)
   5 59.8 (30.5)* 42.4 (42.4) 44.9 (46.3) 46.1 (16.7) 64.4 (20.7) 65.9 (25.9)* 61.2 (29.6)* 38.2 (17.1)*
  5–10 54.5 (28.3) 40.8 (42.9) 44.4 (46.1) 44.2 (20.4) 60.2 (18.1) 60.9 (30.9) 49.1 (31.9) 33.3 (20.8)
   10 45.9 (30.1) 28.3 (34.9) 32.5 (42.2) 39.5 (18.8) 56.7 (20.7) 52.5 (29.9) 47.6 (34.2) 30.9 (30.9)
Smoking status
  Yes 70.8 (25.4)** 52.0 (40.8)* 63.9 (42.8)** 48.7 (16.8) 67.7 (19.2) 72.1 (25.8)* 64.1 (27.8) 45.5 (21.5)**
  No 52.2 (30.7) 36.6 (42.5) 38.3 (45.3) 43.1 (18.5) 60.3 (20.4) 59.6 (28.1) 53.5 (32.1) 33.6 (17.2)
BMI
   27 57.0 (33.3)* 51.1 (43.6)** 50.7 (47.0)* 47.4 (19.1) 66.3 (17.5) 64.6(22.9) 64.6 (23.8) 40.6 (19.0)
  27–33 59.5 (29.5) 43.9 (43.5) 47.2 (45.1) 45.5 (20.1) 62.4 (19.4) 64.8 (29.4) 54.7 (31.0) 35.7 (17.3)
   33 46.6 (28.6) 27.5 (38.1) 32.0 (42.7) 40.4 (15.7) 59.1 (821.1) 56.1 (27.8) 48.4 (32.1) 33.2 (18.5)
Treatment type
   Nonpharmaco-
logical
48.8 (35.8) 36.7 (39.6) 29.2 (29.2) 42.8 (18.5) 59.8 (23.6) 63.9 (22.0) 48.4 (25.9) 33.7 (16.9)*
  Oral 58.3 (30.1) 42.9 (44.0) 49.0 (47.1) 46.0 (17.6) 64.6 (18.5) 62.9 (29.0) 58.6 (32.6) 37.9 (18.3)
  Insulin 48.5 (28.8) 35.3 (42.2) 35.6 (43.6) 40.0 (20.9) 54.3 (23.5) 56.9 (26.6) 51.5 (31.8) 28.9 (19.5)
HbA1c level
   7.5 56.5 (30.0) 39.2 (41.1) 42.4 (45.4) 44.3 (17.6) 62.5 (20.2) 61.5 (29.9) 53.4 (31.2) 36.0 (17.1)
   7.5 51.5 (31.0) 37.5 (43.0) 42.3 (44.9) 42.8 (19.8) 60.7 (20.6) 61.6 (29.8) 54.8 (31.6) 34.3 (18.9)
Disease awareness
  Yes 41.9 (29.7)** 24.5 (24.5)** 28.0 (41.4)** 36.8 (41.4)** 53.8 (17.3)* 51.3 (18.9)** 38.2 (27.7)** 25.9 (18.5)**
  No 57.8 (29.4) 42.5 (43.4) 45.9 (45.2) 45.9 (45.2) 63.9 (18.3) 64.5 (19.8) 58.2 (27.8) 38.2 (18.1)
Notes: * p   0.05; **p   0.01.
Abbreviations: BMI, body mass index; HbA1c, hemoglobin A1c; SF-36, Rand 36-item short form health survey.Patient Preferences and Adherence 2008:2 25
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problem-oriented management behavior and an improved 
quality of life (Anderson et al 2000). If patients believe they 
are able to perform disease-speciﬁ  c behavior, which will be 
relevant to the outcome of the disease, they can positively 
inﬂ  uence health-related quality of life (Aalto et al 1997). 
But if the patient persists with emotion-oriented manage-
ment, this may have a negative impact on psychosocial well 
being, causing an increased sense of burden which in turn 
will affect interactions with others (Watkins et al 2000). The 
longer patients have the illness, the worse they feel. They may 
lose energy, feel fatigue, and their social functioning may 
sharply decrease, as demonstrated in our study. Furthermore, 
we found that being aware of the disease and its possible 
complications negatively affects the patient’s quality of life. 
Our results conﬂ  ict with studies on the psychosocial aspects 
of diabetes, which found that those with extensive knowledge 
and understanding of their disease have a more positive qual-
ity of life (Anderson et al 2000; Watkins et al 2000). How-
ever, similar results to our study were demonstrated among 
patients with hypertension (Li et al 2005). Researchers found 
that subjects aware of having high blood pressure had a lower 
health-related quality of life score than subjects with high 
blood pressure, who were unaware of the diagnosis (Li et al 
2005). The barriers most frequently reported by patients 
in previous studies were helplessness and frustration as a 
result of lack of glycemic control, and continued progres-
sion of the disease despite adherence (Nagelkerk et al 2006). 
Therefore knowledge about the disease is not enough to 
guarantee improved quality of life. However, the results of 
a US study demonstrated that well-informed and motivated 
patients were more successful in obtaining and maintaining 
good control of their risk factors (Rachmani et al 2005). 
The negative effect on patients’ quality of life as a result of 
their greater awareness of the disease, might be inﬂ  uenced 
by differences in information delivery. Whilst patients can 
be educated toward greater autonomy, not all health profes-
sionals are ready to work in partnership with them. The study 
highlighted the importance of clinical staff not only gaining 
a better understanding of diabetes management, but also of 
the theoretical principles underlying patient empowerment 
(Cooper et al 2003).
Conclusions
Our study demonstrated that the most important factors 
affecting the quality of life of patients with type 2 diabetes 
are age, duration of diabetes, BMI, and the extent of their 
understanding and awareness of their disease. BMI and 
patient awareness and understanding of disease are modiﬁ  -
able risk factors, but are extremely challenging issues for 
physicians. Family doctors should work in closer partnership 
with patients in order to enhance their abilities to be more 
autonomous in controlling their own risk factors, and learning 
and maintaining problem-oriented behavior.
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